TAP1 and brain neoplasm: High expression levels of major APM components including TAP1 and HLA class I loci were directly associated with a better outcome for most cancer patients, including skin cutaneous melanoma, with the exception of brain tumors, uveal melanoma and thymoma (Table 1).